Crossref
Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry
BMJ · 08.05.2024 · q975
DOI: 10.1136/bmj.q975 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMJ, online erschienen am 08.05.2024. Verfasst von Peter Doshi. Beteiligte Einrichtung: The BMJ. Hauptthemen laut MEDLINE: United States Food and Drug Administration. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
United States Food and Drug AdministrationUnited StatesHumansDrug IndustryGoverning Board
Autor:innen und Institutionen
- The BMJ.
Zitieren
APA
Doshi, P. (2024). Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry. BMJ, q975. https://doi.org/10.1136/bmj.q975
Vancouver
Doshi P. Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry. BMJ. 2024:q975. doi:10.1136/bmj.q975
BibTeX
@article{Doshi2024,
author = {Doshi, Peter},
title = {Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry},
journal = {BMJ},
year = {2024},
pages = {q975},
doi = {10.1136/bmj.q975}
}
EUVIMED